Shots:

• The P-I/II study of AZD1222 has resumed in Japan following the discussion with the PMDA. Additionally- the company is in talks with the US FDA to facilitate review of the information needed to decide regarding the resumption of the US trial
• A standard review process triggered a voluntary pause to vaccination across all global trials on Sept 06- 2020- to allow the review of safety data by an independent committee
• The resumption follows the restart of clinical study in the UK- Brazil- South Africa- and India

­ Ref: AstraZeneca | Image: Business Standard

Related News: AstraZeneca Resumes COVID-19 Vaccine Trials in the UK